Wet Age-Related Macular Degeneration (AMD) – Market Access and Reimbursement Insights Report – 2025
Wet Age-Related Macular Degeneration (AMD) Market Access and Reimbursement Insights Thelansis’s “Wet Age-Related Macular Degeneration (AMD) Market Access and Reimbursement Insights Report – 2025″ provides comprehensive payer insights on the current and evolving market access and reimbursement environments for branded and emerging drugs in the indication. Our team understands the criticality of payer research and insights generation, as well as their importance during drug development, pre-market launch strategy, and post-marketing activities. Wet Age-Related Macular Degeneration (AMD) Overview Wet Age-Related Macular Degeneration (AMD), also known as neovascular or exudative AMD, is a progressive retinal disorder characterized by the abnormal growth of blood vessels beneath the macula, the central portion of the retina responsible for sharp, detailed vision. These fragile vessels tend to leak blood and fluid, leading to macular scarring and rapid deterioration of central...